Principal, Alpine BioVentures; Chief Business Officer
Dr. Remy Durand joined Alpine BioVentures with over 10 years of experience in life sciences research, consulting and investing. Prior to Alpine BioVentures, Remy was a vice president on the life sciences investment team at Frazier Healthcare Partners, one of the first dedicated healthcare investment firms. During his time at Frazier, Remy was a board observer or director on multiple investments including Alpine Immune Sciences, Aptinyx and Scout Bio. Earlier in his career, he was an investment professional at GE Ventures Healthcare and spent time as a management consultant with LEK Consulting, a premier strategic advisor to the life sciences industry. Remy is also currently the chief business officer at Alpine BioVentures portfolio company Alpine Immune Sciences. Remy earned his Ph.D. in bioengineering from Stanford University, where he was a National Science Foundation Graduate Research Fellow. His doctoral research used optogenetics to map neural circuits and to understand the physiologic basis of functional neural imaging, which resulted in publications in Nature and Nature Protocols.